5VM
ARTV

5AM Venture Management’s Artiva Biotherapeutics ARTV Stock Holding History

5AM Venture Management’s Portfolio ARTV Stock Details ARTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.8M Hold
2,353,304
– – 7.93% 6
2026
Q1 		$15.2M Hold
2,353,304
– – 4.21% 10
2025
Q4 		$10.1M Hold
2,353,304
– – 3.17% 13
2025
Q3 		$6.75M Hold
2,353,304
– – 2.47% 17
2025
Q2 		$3.55M Hold
2,353,304
– – 1.37% 21
2025
Q1 		$7.06M Hold
2,353,304
– – 2.67% 15
2024
Q4 		$23.7M Hold
2,353,304
– – 5.66% 5
2024
Q3 		$36.4M Buy
+2,353,304
New +$27.3M 7.51% 4

Other funds holding ARTV

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

5AM Venture Management's ARTV Position: Q2 2026 in Review

5AM Venture Management held its Artiva Biotherapeutics (ARTV) position steady in Q2 2026 at 2,353,304 shares worth $22.8M. The position accounts for 7.93% of the portfolio, ranked #6.

5AM Venture Management first reported a position in ARTV in Q3 2024 and has held it in 8 quarters since. The position peaked at $36.4M in Q3 2024. 72 funds tracked by Wall St. Rank hold ARTV as of Q2 2026.

  • 5AM Venture Management held 2,353,304 shares of Artiva Biotherapeutics worth $22.8M as of Q2 2026.
  • 5AM Venture Management left its Artiva Biotherapeutics share count unchanged in Q2 2026.
  • Artiva Biotherapeutics made up 7.93% of 5AM Venture Management's portfolio in Q2 2026, its #6 holding.
  • 5AM Venture Management first reported a position in Artiva Biotherapeutics in Q3 2024 and has held it in 8 quarters since.
  • 5AM Venture Management's Artiva Biotherapeutics position peaked at $36.4M in Q3 2024.
  • 72 funds tracked by Wall St. Rank held Artiva Biotherapeutics as of Q2 2026.

Based on 5AM Venture Management's 13F filing for Q2 2026, filed 14 Aug 2026.